Adverum Biotechnologies (LTS:0HA3) Total Long-Term Assets : $48.19 Mil (As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Adverum Biotechnologies Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Adverum Biotechnologies's Total Long-Term Assets for the quarter that ended in Mar. 2025 was $48.19 Mil.

Adverum Biotechnologies Total Long-Term Assets Historical Data

The historical data trend for Adverum Biotechnologies's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adverum Biotechnologies Total Long-Term Assets Chart

Adverum Biotechnologies Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Long-Term Assets

Get a 7-Day Free Trial

48.13

122.58

117.78

53.00

48.54

Adverum Biotechnologies Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Long-Term Assets	Get a 7-Day Free Trial															68.70	74.39	73.30	48.54	48.19

Adverum Biotechnologies Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Adverum Biotechnologies Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of Adverum Biotechnologies's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Adverum Biotechnologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adverum Biotechnologies Inc (LTS:0HA3) » Definitions » Total Long-Term Assets

Comparable Companies

Traded in Other Exchanges

ADVM:USA AVU0:Germany

Address

100 Cardinal Way, Redwood CIty, CA, USA, 94063

Website

https://www.adverum.com

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

Adverum Biotechnologies Headlines

No Headlines